A real-world comparison of celiac tissue transglutaminase immunoglobulin A antibody levels in pediatric patients using two different diagnostic kits.
7 affiliations
- 1Pediatric Gastroenterology Kaplan Medical Center Rehovot Israel.
- 2Faculty of Medicine Hebrew University of Jerusalem Jerusalem Israel.
- 3Institute of Gastroenterology, Nutrition and Liver Diseases Schneider Children's Medical Center of Israel Petach Tikva Israel.
- 4Gray Faculty of Medical and Health Sciences Tel-Aviv University Tel Aviv Israel.
- 5Gastroenterology Laboratory, Rabin Medical Center Petach Tikva Israel.
- 6Department of Digital Medical technologies Holon Institute of Technology Holon Israel.
- 7Data Research Department Academy, Research and Innovation Authority, Kaplan Medical Center Rehovot Israel.
Abstract
Objectives
Pediatric celiac disease (CeD) may be diagnosed without a biopsy when tissue-transglutaminase (TTG) immunoglobulin A (IgA) antibodies are ≥10x the upper limit of normal (ULN) and anti-endomysial antibodies are positive in a second sample. The no-biopsy diagnosis demands a very high accuracy and reliability of the TTG diagnostic kits. Inter-assay differences may affect category classification. We compared TTG-IgA levels performed by two reliable kits: Bioplex 2200 and Liaison-XL in routine care.Methods
Using the Clalit Health Services database, we identified pediatric patients with paired TTG-IgA measurements from both kits within ≤14 days. Values were expressed as multiples of ULN and categorized: 10x ULN. Agreement was assessed for ≤7 and ≤14-day windows using Cohen's ĸ.Results
Category discordance occurred in 17.4% (109/625) of paired tests within 14 days and 11.8% (38/321) within 7 days. Overall agreement was substantial (ĸ = 0.62 for 14 days; ĸ = 0.63 for 7 days). Concordance was high for negative results (96.0%), but significantly lower for the critical >10x ULN threshold at 14 days (88.2%, p = 0.009).Conclusions
Significant discordance between these two reliable TTG-IgA kits at 14 days, exceeding 10% in the >10x ULN category, warrants careful consideration when using the no-biopsy approach for CeD diagnosis, as assay choice may impact clinical classification.
Related
- Association Between Tissue Transglutaminase IgA Levels and Villous Atrophy in Pediatric Celiac Disease: A Retrospective Cross-Sectional Study
- Characteristics of hospitalized children with immunoglobulin A vasculitis: a 7-year retrospective study of 119,217 pediatric inpatients in China.
- Clinical Analysis and Diagnostic Challenges of Immunoglobulin G4-Related Disease Involving the Salivary Gland: A Single Center Retrospective Analysis of 24 Cases
- PP–005 Same storm, different sparks: pediatric hyperinflammation with distinct underlying triggers
- Multimodal neuroimaging and electrophysiological signatures in amnestic mild cognitive impairment with different amyloid-β deposition status: correlations with cognitive function and diagnostic value
BibTeX
@article{kori2026realworld,
title = {{A real-world comparison of celiac tissue transglutaminase immunoglobulin A antibody levels in pediatric patients using two different diagnostic kits.}},
author = {Michal Kori and Anat Guz-Mark and Tsachi Tsadok Perets and Amit Davidpur and Assaf Hoofien and Raanan Shamir},
journal = {JPGN reports},
year = {2026},
month = nov,
doi = {10.1002/jpr3.70287},
url = {https://europepmc.org/article/MED/43011603},
note = {CC BY-NC-ND},
}
RIS
TY - JOUR
TI - A real-world comparison of celiac tissue transglutaminase immunoglobulin A antibody levels in pediatric patients using two different diagnostic kits.
AU - Michal Kori
AU - Anat Guz-Mark
AU - Tsachi Tsadok Perets
AU - Amit Davidpur
AU - Assaf Hoofien
AU - Raanan Shamir
PY - 2026
DA - 2026/11/09
JO - JPGN reports
DO - 10.1002/jpr3.70287
UR - https://europepmc.org/article/MED/43011603
AB - Objectives Pediatric celiac disease (CeD) may be diagnosed without a biopsy when tissue-transglutaminase (TTG) immunoglobulin A (IgA) antibodies are ≥10x the upper limit of normal (ULN) and anti-endomysial antibodies are positive in a second sample. The no-biopsy diagnosis demands a very high accuracy and reliability of the TTG diagnostic kits. Inter-assay differences may affect category classification. We compared TTG-IgA levels performed by two reliable kits: Bioplex 2200 and Liaison-XL in routine care.Methods Using the Clalit Health Services database, we identified pediatric patients with paired TTG-IgA measurements from both kits within ≤14 days. Values were expressed as multiples of ULN and categorized: 10x ULN. Agreement was assessed for ≤7 and ≤14-day windows using Cohen's ĸ.Results Category discordance occurred in 17.4% (109/625) of paired tests within 14 days and 11.8% (38/321) within 7 days. Overall agreement was substantial (ĸ = 0.62 for 14 days; ĸ = 0.63 for 7 days). Concordance was high for negative results (96.0%), but significantly lower for the critical >10x ULN threshold at 14 days (88.2%, p = 0.009).Conclusions Significant discordance between these two reliable TTG-IgA kits at 14 days, exceeding 10% in the >10x ULN category, warrants careful consideration when using the no-biopsy approach for CeD diagnosis, as assay choice may impact clinical classification.
SN - 2691-171X
ER -